Leave Your Message

Revolutionary Immunofluorescence System Transforms Arthritis Subtyping

2025-10-12

#ImmunofluorescenCeassay #ArthritisScreening #AntiCCPTesting #RheumatoidFactor #InflammationMarkers #POCTInnovation

The Global Arthritis Burden: Critical Diagnostic Gaps
WHO 2025 Data Insights

 

Of nearly 500 million arthritis patients globally, over 60% do not receive early specific antibody testing.

 62262946_10157339508634886_3334181544221736960_n.jpg

 

Status of high-risk groups in the world:
▶️ Rheumatoid Arthritis prevalence exceeds 20% in middle-aged and elderly women.
▶️ 30% of patients with early undifferentiated arthritis progress to RA within one year.

 

 

Value of Early Intervention:
+ Early intervention for Anti-CCP positivity can delay joint erosion by up to 70%.

 

Technical Breakthrough: Quantitative Immunofluorescence System
"The system utilizes LED excitation light sources. Fluorescent signals are photoelectrically converted to precisely quantify the concentration of various arthritis markers."

Performance Advantages

Traditional Challenge

System Solution

Clinical Value

Limited to single-analyte detection

8 independent channels; simultaneous testing for Anti-CCP, RF, hs-CRP, ASO, etc.

Completes arthritis subtyping in one run

Low sensitivity, high missed diagnosis rate

High-sensitivity IFA, detection limit as low as 0.1 IU/mL

Early detection of seronegative arthritis

Complex operation, inconsistent calibration

Pre-programmed calibration curves, automatic QC

High correlation with central lab results

Operational Workflow (Brochure Page 2)
Insert specialized test cassette → Apply sample → LED excites fluorescent dye → Photoelectric signal conversion → Automatic concentration calculation and result display

Arthritis-Related Assay Performance

Anti-CCP Immunofluorescence Assay
Linear Range: 10–500 U/mL
Time to Result: 15 minutes
Sample Type: 120μL whole blood,100μL serum/plasma

Rheumatoid Factor (RF) Assay
Linear Range: 10–160 IU/mL
High specificity, minimizes false positives

High-Sensitivity C-Reactive Protein (hs-CRP) Assay
Range: 0.5–200 mg/L
Early inflammation assessment, aids differentiation of inflammatory vs. non-inflammatory arthritis

Anti-Streptolysin O (ASO) Assay
Range: 10–500 U/mL
Supports differential diagnosis of post-streptococcal reactive arthritis

Quality Control (Brochure Page 2)

 

Room-temperature stable QC materials

Two-level controls ensuring result reliability

 

Device Integration Highlights
Multi-Channel High-Efficiency Testing
Supports simultaneous testing of 10 items, e.g., Anti-CCP + RF + hs-CRP + ASO + other inflammatory markers.

网站用11.jpg

Connectivity & Usability
7-inch touchscreen
50,000 result storage capacity
LIS/HIS connectivity & auto-printing
Portable design: 269×130×137mm / 1.5kg

Smart Result Interpretation & Referral Suggestions

 

Red: Anti-CCP > 50 IU/mL or RF > 60 IU/mL → Recommend rheumatology consultation within 72 hours.

 

Yellow: Elevated ASO or mild elevation of hs-CRP → AI-recommended further evaluation and follow-up plan.

Data Management
Cloud-based "Arthritis Digital Tracker" platform.
Longitudinal tracking of inflammatory marker trends, assisting treatment evaluation and disease management.


#ImmunofluorescenceAssay #QuantitativePOCT  #MultiChannelSystem #PreprogrammedCalibration
#EarlyArthritisScreening #RheumatoidFactorTesting #CombinedInflammationMarkerTesting